Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 10Breast Neoplasms 10Leukemia 9Carcinoma, Ovarian Epithelial 8Ovarian Neoplasms 7Multiple Myeloma 7Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Myelodysplastic Syndromes 6Melanoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Astrocytoma 6Lymphoma, Follicular 5Lung Neoplasms 5Brain Neoplasms 5Oligodendroglioma 4Neoplasms, Plasma Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hodgkin Disease 4

Interventions

temsirolimus 2Sirolimus 2Gemcitabine 2ARQ 197 2veliparib 1sargramostim 1pegfilgrastim 1ixabepilone 1cixutumumab 1belinostat 1Vorinostat 1Topotecan 1Tolbutamide 1Taxes 1Sunitinib 1Rifampin 1Paclitaxel 1Omeprazole 1Midazolam 1Ketoconazole 1Isotretinoin 1Irinotecan 1Introns 1Interferon alpha-2 1Hydroxychloroquine 1Erlotinib Hydrochloride 1Epothilones 1Dextromethorphan 1Colony-Stimulating Factors 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adult Solid Neoplasm × sargramostim × Clear all
NCT00217373 2015-04-20

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

National Cancer Institute (NCI)

Phase 1 Completed
33 enrolled

Adult Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡